Johnson & Johnson to Buy Ollin Biosciences for Up to $3.4 Billion
Johnson & Johnson is set to acquire privately held Ollin Biosciences for up to $3.4 billion.
Johnson & Johnson is set to acquire privately held Ollin Biosciences for up to $3.4 billion.